Articles | EuroIntervention

• May 25, 2010

Acute left main obstructions following TAVI

Stabile E, Sorropago G, Cioppa A, Cota L, Agrusta M, Lucchetti V, Rubino P

free

• May 25, 2010

Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction

de Boer M, Hoorntje J, Gosselink A, Suryapranata H, van 't Hof AW

free

• May 25, 2010

A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated By EveroLimus-Eluting Stent) trial

Moreno R, Garcia E, Teles RC, Almeida M, Carvalho H, Sabaté M, Martin-Reyes R, Rumoroso J-R, Galeote G, Goicolea F, Moreu J, Mainar V, Mauri J, Ferreira R, Valdes M, Perez de Prado A, Martin-Yuste V, Jiménez-Valero S, Sanchez Recalde A, Calvo L, de Sa E, Macaya C, López-Sendón J-L

free

• May 25, 2010

Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimus and tacrolimus-eluting stents

van Beusekom H, Sorop O, van den Heuvel M, Onuma Y, Duncker D, Danser A, van der Giessen WJ

free

• May 25, 2010

Polymer-free cerivastatin-eluting stent shows superior neointimal inhibition with preserved vasomotor function compared to polymer-based paclitaxel-eluting stent in rabbit iliac arteries

Pendyala L, Yin X, Li J, Shinke T, Xu Y, Chen J, King S, Colley K, Goodchild T, Chronos N, Hou D

free

• May 25, 2010

A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan

Segev A, Nili N, Osherov A, Qiang B, Wong A, Pillarisetti S, Strauss B